Literature DB >> 21763284

miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma.

Chun-Mei Wang1, Yan Wang, Chun-Guang Fan, Fei-Fei Xu, Wen-Sheng Sun, Yu-Gang Liu, Ji-Hui Jia.   

Abstract

Recent studies have revealed that microRNA-29c (miR-29c) is involved in a variety of biological processes including carcinogenesis. Here, we report that miR-29c was significantly downregulated in hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) cell lines as well as in clinical tissues compared with their corresponding controls. Tumor necrosis factor alpha-induced protein 3 (TNFAIP3), a key regulator in inflammation and immunity, was found to be inversely correlated with miR-29c levels and was identified as a target of miR-29c. Overexpression of miR-29c in HepG2.2.15 cells effectively suppressed TNFAIP3 expression and HBV DNA replication as well as inhibited cell proliferation and induced apoptosis. We conclude that miR-29c may play an important role as a tumor suppressive microRNA in the development and progression of HBV-related HCC by targeting TNFAIP3. Thus miR-29c and TNFAIP3 represent key diagnostic markers and potential therapeutic targets for the prevention and treatment of HBV infection.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763284     DOI: 10.1016/j.bbrc.2011.06.191

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  70 in total

1.  Hepatitis B virus molecular biology and pathogenesis.

Authors:  R Jason Lamontagne; Sumedha Bagga; Michael J Bouchard
Journal:  Hepatoma Res       Date:  2016-07-01

Review 2.  MicroRNA: master controllers of intracellular signaling pathways.

Authors:  Pak-Yin Lui; Dong-Yan Jin; Nigel J Stevenson
Journal:  Cell Mol Life Sci       Date:  2015-06-10       Impact factor: 9.261

3.  MicroRNAs in Liver Disease: Bench to Bedside.

Authors:  Nihar Shah; James E Nelson; Kris V Kowdley
Journal:  J Clin Exp Hepatol       Date:  2013-09-17

Review 4.  Regulation of NF-κB by deubiquitinases.

Authors:  Edward W Harhaj; Vishva M Dixit
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

5.  Interplay of Toll-Like Receptor 9, Myeloid Cells, and Deubiquitinase A20 in Periodontal Inflammation.

Authors:  Katie E Crump; Jennifer C Oakley; Xia Xia-Juan; Theandra C Madu; Swathi Devaki; Erin C Mooney; Sinem E Sahingur
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

Review 6.  Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases.

Authors:  Jason Lamontagne; Laura F Steel; Michael J Bouchard
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

Review 7.  Host cellular microRNA involvement in the control of hepatitis B virus gene expression and replication.

Authors:  Yoshiaki Mizuguchi; Toshihiro Takizawa; Eiji Uchida
Journal:  World J Hepatol       Date:  2015-04-08

8.  Expression of A20 is reduced in pancreatic cancer tissues.

Authors:  Qing Wang; Lijuan Yuan; Ziyu Liu; Jikai Yin; Xue Jiang; Jianguo Lu
Journal:  J Mol Histol       Date:  2012-03-30       Impact factor: 2.611

9.  Tranilast induces MiR-200c expression through blockade of RelA/p65 activity in leiomyoma smooth muscle cells.

Authors:  Tsai-Der Chuang; Amit Rehan; Omid Khorram
Journal:  Fertil Steril       Date:  2020-03-18       Impact factor: 7.329

Review 10.  microRNAs in liver disease: from diagnostics to therapeutics.

Authors:  Kenji Takahashi; Irene Yan; Hui-Ju Wen; Tushar Patel
Journal:  Clin Biochem       Date:  2013-02-07       Impact factor: 3.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.